Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

Completed · Phase 3

Conditions studied: Eyelashes

In brief

This study evaluates the safety and effectiveness of topical bimatoprost solution for enhancing eyelash prominence.

Key facts

Study ID

NCT00693420

Run by

Allergan

People needed

278

Starts

2007-04-01

Expected to finish

2007-12-01

Last updated by the study team

2013-10-30

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Dissatisfaction with eyelash prominence,
• Eyelash prominence assessment of minimal or moderate,
• Ability to provide written informed consent

You may not qualify if…

• Subjects without visible lashes,
• Asymmetrical (uneven lashes or longer on one side than the other) eyelashes,
• Any eye disease or abnormality,
• Eye surgery,
• Permanent eyeliner,
• Eyelash implants,
• Eyelash extension application,
• Any use of eyelash growth products within 6 months of study entry,
• Treatments that may effect hair growth,
• Subjects requiring eye drop medications for glaucoma,
• Subjects having a situation or condition, which the study doctor feels might put you at risk, may make the study results confusing, or may interfere with the study.

Where it is running

• Study site — San Diego, California, United States
• Study site — Vancouver, British Columbia, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.